Midatech Pharma NASDAQ MTP
- - -%
Today share price
UK
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 29 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

712.90K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

-1.96M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.66
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

5.42M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events Midatech Pharma All events
No upcoming events scheduled

Stock chart Midatech Pharma

Stock analysis Midatech Pharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
0.08 13.17
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.23 3.74
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.21 9.25
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.28 0.06
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
275.46 9.43

Price change Midatech Pharma per year

1.62$ 3.55$
Min Max

Summary analysis Midatech Pharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Midatech Pharma

Revenue and net income Midatech Pharma

All parameters
Stock news Midatech Pharma All news

Midatech Pharma to Raise About $6 Million to Develop Cancer Treatment

Midatech Pharma to Raise About $6 Million to Develop Cancer Treatment

Midatech Pharma Shares Fall on Risk of Entering Into Administration

Midatech Pharma Shares Fall on Risk of Entering Into Administration

Midatech Pharma Shares Rise on Revised Placement Terms, Intention to Remain on AIM

Midatech Pharma Shares Rise on Revised Placement Terms, Intention to Remain on AIM

Midatech Pharma Shares Fall on Bioasis Technologies Buy, Plan to Cancel AIM Listing

Midatech Pharma Shares Fall on Bioasis Technologies Buy, Plan to Cancel AIM Listing

Midatech Pharma Will Need Extra Financing in 1Q 2023; Mulling Options

Midatech Pharma Will Need Extra Financing in 1Q 2023; Mulling Options

Midatech Pharma Cancer Treatment Gets Orphan Designation From EMA

Midatech Pharma Cancer Treatment Gets Orphan Designation From EMA

Midatech Pharma Chairman Rolf Stahel to Retire; Appoints Stephen Parker to Role

Midatech Pharma Chairman Rolf Stahel to Retire; Appoints Stephen Parker to Role

Midatech Pharma Shares Rise on FDA Fast Track Designation for Cancer Treatment

Midatech Pharma Shares Rise on FDA Fast Track Designation for Cancer Treatment

Midatech Pharma Flags Possible Doubt About Ability to Continue as Going Concern

Midatech Pharma Flags Possible Doubt About Ability to Continue as Going Concern

Midatech Pharma Extends R&D Collaboration With Janssen

Midatech Pharma Extends R&D Collaboration With Janssen

About company Midatech Pharma

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Address:
Oddfellows House, Cardiff, United Kingdom, CF24 0AA
Company name: Midatech Pharma
Issuer ticker: MTP
ISIN: US59564R3021
Country: UK
Exchange: NASDAQ
Currency: $
IPO date: 2015-12-07
Sector: Healthcare
Industry: Biotechnology
Site: https://www.midatechpharma.com

On which stock exchange are Midatech Pharma (MTP) stocks traded?

Midatech Pharma (MTP) stocks are traded on NASDAQ.

What is the ticker of Midatech Pharma stocks (MTP)?

The stock ticker of Midatech Pharma’s stocks or in other words, the code is MTP. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Midatech Pharma (MTP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Midatech Pharma (MTP) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Midatech Pharma (MTP) stocks traded?

Midatech Pharma (MTP) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Midatech Pharma (MTP) stocks today?

The current price of Midatech Pharma stocks on 29.04.2024 is dollars. per share.

What is the dynamics of Midatech Pharma (MTP) stocks from the beginning of the year?

Midatech Pharma (MTP) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Midatech Pharma (MTP) stocks increase in апреле 2024?

This month Midatech Pharma (MTP) quotes have increased by 0% to dollars. per share.

How much are Midatech Pharma (MTP) stocks worth?

Today, on October, 29.04.2024 Midatech Pharma’s (MTP) stocks cost dollars..

What is the market capitalization of Midatech Pharma (MTP)?

Capitalization is the market value of Midatech Pharma (MTP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Midatech Pharma (MTP) is estimated at about 712895 dollars.